Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT Cash & Equivalents

Cash & Equivalents at other companies

TFX
TeleflexTFX
$316.92M+23.5%
Boston Scientific logo
Boston ScientificBSX
$850M+146%
Intuitive Surgical logo
Intuitive SurgicalISRG
$2.81B-18.6%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$31.14M+0.4%
PDE
Pro-Dex, Inc.PDEX
$9.99M+123%
Microbot Medical logo
Microbot MedicalMBOT
$3.66M+13.7%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B—
P/S3.4×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030

FAQ

What is PROCEPT BioRobotics Corporation's cash & equivalents?
PROCEPT BioRobotics Corporation (PRCT) reported cash & equivalents of $11.42M in Q2 2026.
How has PROCEPT BioRobotics Corporation's cash & equivalents changed year-over-year?
PROCEPT BioRobotics Corporation's cash & equivalents decreased by 96.3% year-over-year, from $305.76M to $11.42M.
What is the long-term trend for PROCEPT BioRobotics Corporation's cash & equivalents?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's cash & equivalents has grown at a -42.6% compound annual growth rate (CAGR), from $100.91M to $6.29M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about PROCEPT BioRobotics Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude